Browse by Journal Title

Article

Discrimination of multiple sclerosis using OCT images from two different centers.
Khodabandeh, Z. and Rabbani, H. and Ashtari, F. and Zimmermann, H.G. and Motamedi, S. and Brandt, A.U. and Paul, F. and Kafieh, R.
Multiple Sclerosis and Related Disorders 77 : 104846. September 2023

Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Lin, T.Y. and Schindler, P. and Grittner, U. and Oertel, F.C. and Lu, A. and Motamedi, S. and Yadav, S.K. and Duchow, A.S. and Jarius, S. and Kuhle, J. and Benkert, P. and Brandt, A.U. and Bellmann-Strobl, J. and Schmitz-Hübsch, T. and Paul, F. and Ruprecht, K. and Zimmermann, H.G.
Multiple Sclerosis and Related Disorders 67 : 104100. November 2022

Fragmentation, circadian amplitude, and fractal pattern of daily-living physical activity in people with multiple sclerosis: is there relevant information beyond the total amount of physical activity?
Salomon, A. and Galperin, I. and Buzaglo, D. and Mirelman, A. and Regev, K. and Karni, A. and Schmitz-Hübsch, T. and Paul, F. and Devos, H. and Sosnoff, J.J. and Tamir, R. and Shimoni, N. and Hausdorff, J.M.
Multiple Sclerosis and Related Disorders 68 : 104108. 2 September 2022

Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: evaluation of 794 attacks from a nationwide registry in Argentina.
Carnero Contentti, E. and Lopez, P.A. and Pettinicchi, J.P. and Criniti, J. and Pappolla, A. and Miguez, J. and Patrucco, L. and Cristiano, E. and Liwacki, S. and Tkachuk, V. and Balbuena, M.E. and Vrech, C. and Deri, N. and Correale, J. and Marrodan, M. and Ysrraelit, M.C. and Leguizamon, F. and Luetic, G. and Menichini, M.L. and Tavolini, D. and Mainella, C. and Zanga, G. and Burgos, M. and Hryb, J. and Barboza, A. and Lazaro, L. and Alonso, R. and Fernández Liguori, N. and Nadur, D. and Chercoff, A. and Alonso Serena, M. and Caride, A. and Paul, F. and Rojas, J.I.
Multiple Sclerosis and Related Disorders 58 : 103466. February 2022

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
Chen, J.J. and Sotirchos, E.S. and Henderson, A.D. and Vasileiou, E.S. and Flanagan, E.P. and Bhatti, M.T. and Jamali, S. and Eggenberger, E.R. and Dinome, M. and Frohman, L.P. and Arnold, A.C. and Bonelli, L. and Seleme, N. and Mejia-Vergara, A.J. and Moss, H.E. and Padungkiatsagul, T. and Stiebel-Kalish, H. and Lotan, I. and Hellmann, M.A. and Hodge, D. and Oertel, F.C. and Paul, F. and Saidha, S. and Calabresi, P.A. and Pittock, S.J.
Multiple Sclerosis and Related Disorders 58 : 103525. February 2022

AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R. and Pittock, S.J. and Paul, F. and Kim, H.J. and Bennett, J. L. and Weinshenker, B.G. and Wingerchuk, D.M. and Green, A.J. and Fujihara, K. and Cutter, G. and Aktas, O. and Hartung, H.P. and Drappa, J. and Ratchford, J.N. and She, D. and Smith, M. and Rees, W. and Cimbora, D. and Katz, E. and Cree, B.A.C.
Multiple Sclerosis and Related Disorders 57 : 103356. January 2022

Characteristics of secondary progressive multiple sclerosis: disease activity and provision of care in Germany - a registry-based/multicentric cohort study.
Frahm, N. and Ellenberger, D. and Fneish, F. and Christoph, K. and Warnke, C. and Zettl, U.K. and Paul, F. and Rauser, B. and Stahmann, A. and Vogelmann, V. and Flachenecker, P.
Multiple Sclerosis and Related Disorders 56 : 103281. November 2021

The Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.
Soares-dos-Reis, R. and Tsz-Ching, J.L. and Kim, S.H. and Jacob, A. and Whittam, D. and Berthelot, E. and Paul, F. and Nakashima, I. and Tye, J.S.N. and De Seze, J. and Jitprapaikulsan, J. and Tan, K. and Yang, L. and Elsone, L. and Leite, M.I. and Mealy, M.A. and Levy, M. and Fan, M. and Siebert, N. and Asgari, N. and Cabre, P. and Siritho, S. and Pittock, S.J. and Wing-Ho, S.C. and Senger, T. and Yeo, T. and Takai, Y. and Pandit, L. and Kim, H.J. and Palace, J.
Multiple Sclerosis and Related Disorders 53 : 103080. August 2021

Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Asseyer, S. and Kuchling, J. and Gaetano, L. and Komnenić, D. and Siebert, N. and Chien, C. and Scheel, M. and Oertel, F.C. and Ruprecht, K. and Bellmann-Strobl, J. and Finke, C. and Chakravarty, M.M. and Magon, S. and Wuerfel, J. and Paul, F. and Papadopoulou, A. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 46 : 102579. November 2020

Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
Ellenberger, D. and Flachenecker, P. and Haas, J. and Hellwig, K. and Paul, F. and Stahmann, A. and Warnke, C. and Zettl, U.K. and Rommer, P.S.
Multiple Sclerosis and Related Disorders 46 : 102485. November 2020

Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
Chavarro, V.S. and Bellmann-Strobl, J. and Zimmermann, H.G. and Scheel, M. and Chien, C. and Oertel, F.C. and Weygandt, M. and Ruprecht, K. and Paul, F. and Finke, C. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 45 : 102406. October 2020

Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients.
Whittam, D.H. and Cobo-Calvo, A. and Lopez-Chiriboga, A.S. and Pardo, S. and Gornall, M. and Cicconi, S. and Brandt, A. and Berek, K. and Berger, T. and Jelcic, I. and Gombolay, G. and Oliveira, L.M. and Callegaro, D. and Kaneko, K. and Misu, T. and Capobianco, M. and Gibbons, E. and Karthikeayan, V. and Brochet, B. and Audoin, B. and Mathey, G. and Laplaud, D. and Thouvenot, E. and Cohen, M. and Tourbah, A. and Maillart, E. and Ciron, J. and Deschamps, R. and Biotti, D. and Rostasy, K. and Neuteboom, R. and Hemingway, C. and Forsyth, R. and Matiello, M. and Webb, S. and Hunt, D. and Murray, K. and Hacohen, Y. and Lim, M. and Leite, M.I. and Palace, J. and Solomon, T. and Lutterotti, A. and Fujihara, K. and Nakashima, I. and Bennett, J.L. and Pandit, L. and Chitnis, T. and Weinshenker, B.G. and Wildemann, B. and Sato, D.K. and Kim, S.H. and Huda, S. and Kim, H.J. and Reindl, M. and Levy, M. and Jarius, S. and Tenembaum, S. and Paul, F. and Pittock, S. and Marignier, R. and Jacob, A.
Multiple Sclerosis and Related Disorders 44 : 102251. September 2020

Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.
Chawla, S. and Ge, Y. and Wuerfel, J. and Asadollahi, S. and Mohan, S. and Paul, F. and Sinnecker, T. and Kister, I.
Multiple Sclerosis and Related Disorders 42 : 102066. July 2020

Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: results of an international survey.
D'Souza, M. and Papadopoulou, A. and Levy, M. and Jacob, A. and Yeaman, M.R. and Kümpfel, T. and Marignier, R. and Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 41 : 102027. June 2020

Prodromal headache in MOG-antibody positive optic neuritis.
Asseyer, S. and Hamblin, J. and Messina, S. and Mariano, R. and Siebert, N. and Everett, R. and Küker, W. and Bellmann-Strobl, J. and Ruprecht, K. and Jarius, S. and Leite, M.I. and Brandt, A. and Paul, F. and Palace, J.
Multiple Sclerosis and Related Disorders 40 : 101965. May 2020

Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosis.
Weygandt, M. and Behrens, J. and Brasanac, J. and Söder, E. and Meyer-Arndt, L. and Wakonig, K. and Ritter, K. and Brandt, A.U. and Bellmann-Strobl, J. and Gold, S.M. and Haynes, J.D. and Paul, F.
Multiple Sclerosis and Related Disorders 33 : 139-145. August 2019

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy, M.A. and Mossburg, S.E. and Kim, S.H. and Messina, S. and Borisow, N. and Lopez-Gonzalez, R. and Ospina, J.P. and Scheel, M. and Yeshokumar, A.K. and Awad, A. and Leite, M.I. and Arango, J.A.J. and Paul, F. and Palace, J. and Kim, H.J. and Levy, M.
Multiple Sclerosis and Related Disorders 28 : 64-68. February 2019

Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
Mealy, M.A. and Cook, L.J. and Pache, F. and Velez, D.L. and Borisow, N. and Becker, D. and Jimenez Arango, J.A. and Paul, F. and Levy, M.
Multiple Sclerosis and Related Disorders 23 : 78-82. July 2018

Frequent retinal ganglion cell damage after acute optic neuritis.
Brandt, A.U. and Specovius, S. and Oberwahrenbrock, T. and Zimmermann, H.G. and Paul, F. and Costello, F.
Multiple Sclerosis and Related Disorders 22 : 141-147. May 2018

Magnetic resonance imaging findings at the first episode of acute optic neuritis.
Soelberg, K. and Skejoe, H.P.B. and Grauslund, J. and Smith, T.J. and Lillevang, S.T. and Jarius, S. and Wildemann, B. and Paul, F. and Asgari, N.
Multiple Sclerosis and Related Disorders 20 : 30-36. February 2018

What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).
Heesen, C. and Pöttgen, J. and Rahn, A.C. and Liethmann, K. and Kasper, J. and Vahter, L. and Drulovic, J. and Van Nunen, A. and Wilkie, D. and Beckmann, Y. and Paul, F. and Köpke, S. and Giordano, A. and Solari, A.
Multiple Sclerosis and Related Disorders 18 : 186-195. November 2017

Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study.
Kessler, R.A. and Mealy, M.A. and Jimenez-Arango, J.A. and Quan, C. and Paul, F. and López, R. and Hopkins, S. and Levy, M.
Multiple Sclerosis and Related Disorders 17 : 198-201. October 2017

Severe structural and functional visual system damage leads to profound loss of Vision-related quality of life in patients with neuromyelitis optica spectrum disorders.
Schmidt, F. and Zimmermann, H. and Mikolajczak, J. and Oertel, F.C. and Pache, F. and Weinhold, M. and Schinzel, J. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 11 : 45-50. January 2017

Review

MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
Narayan, R. and Simpson, A. and Fritsche, K. and Salama, S. and Pardo, S. and Mealy, M. and Paul, F. and Levy, M.
Multiple Sclerosis and Related Disorders 25 : 66-72. October 2018